Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology-Clinical Diagnosis: Neuroendocrine

Comparison of 18F-FDG PET and 99mTc-TOC scintigraphy in patients with neuroendocrine tumor

Hongli Jing, Fang Li, Zhaohui Zhu and Yanrong Du
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1260;
Hongli Jing
1Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fang Li
1Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhaohui Zhu
1Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanrong Du
1Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1260

Objectives This study was designed to investigate the complementary value of 18F-FDG PET/CT to 99mTc-EDDA/HYNIC-TOC (99mTc-TOC) scintigraphy in detection of neuroendocrine tumor.

Methods Twenty-eight patients (14 M, 14 F; 19-70 y) with histological confirmed neuroendocrine tumors were included. All patients underwent both 99mTc-TOC scintigraphy and 18F-FDG PET/CT scan within 2 weeks. The patients were divided into single-tumor group (n = 13) and multiple-tumor group (n = 15) for comparison. Standardized uptake values (SUVs) of 18F-FDG positive lesions and tumor to liver ratios of 99mTc-TOC positive lesions were measured for semi-quantitative analysis.

Results In case-based analysis, the sensitivity of 99mTc-TOC scintigraphy was 85.7% ( 24/28), while 18F-FDG PET/CT had positive findings in 96.4% (27/28) patients. The patient misdiagnosed by PET had a single tumor <1 cm in the lung. In lesion-based analysis, 18F-FDG PET detected 87/88 (98.9%) of tumor foci, and the maximum SUVs in lesions with multiple tumors were significantly higher than those in patients with single tumor (8.04±4.98 vs. 3.35±1.61, P=0.002). On the other hand, 99mTc-TOC scintigraphy only identified 55/88 (62.5%) of the tumors, and it showed higher sensitivity in detection of tumors in single-tumor group than in multiple-tumor group (84.6% vs. 57.9%). In spite of the small tumors that was more easily to be negative, 99mTc-TOC scintigraphy usually missed the lesions at lymph nodes (77.8%) and bones (81.0%). In the 15 patients with multiple tumors, the staging and clinical management of 5 patients were changed by 18F-FDG PET/CT.

Conclusions 18F-FDG PET/CT is a sensitive method to complement 99mTc-TOC scintigraphy for detection of neuroendocrine tumors. For the patients with multiple tumors, it may change the management by finding more lesions, especially for lymph node and bone involvement

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of 18F-FDG PET and 99mTc-TOC scintigraphy in patients with neuroendocrine tumor
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of 18F-FDG PET and 99mTc-TOC scintigraphy in patients with neuroendocrine tumor
Hongli Jing, Fang Li, Zhaohui Zhu, Yanrong Du
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1260;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of 18F-FDG PET and 99mTc-TOC scintigraphy in patients with neuroendocrine tumor
Hongli Jing, Fang Li, Zhaohui Zhu, Yanrong Du
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1260;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology-Clinical Diagnosis: Neuroendocrine

  • Glucagon-like peptide-1 vs. somatostatin receptor targeting in malignant insulinoma
  • Detection of intestinal NET by (68)Ga-DOTATOC PET/multiphase CT
Show more Oncology-Clinical Diagnosis: Neuroendocrine

Neuroendocrine Posters

  • Detection of intestinal NET by (68)Ga-DOTATOC PET/multiphase CT
  • Glucagon-like peptide-1 vs. somatostatin receptor targeting in malignant insulinoma
  • Somatostatin receptor expression in metastatic NET lesions depends on primary tumor site
Show more Neuroendocrine Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire